Rofecoxib 12.5 mg, rofecoxib 25 mg, and celecoxib 200 mg in the treatment of symptomatic osteoarthritis: results of two similarly designed studies

By Smugar Steven S.   Schnitzer Thomas J.   Weaver Arthur L.   Rubin Bernard R.   Polis Adam B.   Tershakovec Andrew M.  

Current Medical Research and Opinion, Vol. 22, Iss. 7, 2006-07 ,pp. : 1353-1367

Informa Healthcare

Access to resources Recommend Favorite

The efficacy of rofecoxib 50 mg and hydrocodone/acetaminophen 7.5/750 mg in patients with post-arthroscopic pain

By Chelly Jacques E.   Nissen Carl W.   Rodgers Anthony J.   Smugar Steven S.   Tershakovec Andrew M.  

Current Medical Research and Opinion, Vol. 23, Iss. 1, 2007-01 ,pp. : 195-206

Informa Healthcare

Access to resources Recommend Favorite

Efficacy, safety and tolerability of duloxetine 60 mg once daily in major depression

By Cowen Philip J.   Ogilvie Alan D.   Gama Joubert  

Current Medical Research and Opinion, Vol. 21, Iss. 3, 2005-03 ,pp. : 345-356

Informa Healthcare

Access to resources Recommend Favorite

Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder*

By Liebowitz Michael R.   Manley Amy L.   Padmanabhan Sudharshan K.   Ganguly Rita   Tummala Raj   Tourian Karen A.  

Current Medical Research and Opinion, Vol. 24, Iss. 7, 2008-07 ,pp. : 1877-1890

Informa Healthcare

Access to resources Recommend Favorite

Comment and reply on: Efficacy and safety of the single pill combination of amlodipine 10 mg plus valsartan 160 mg in hypertensive patients not controlled by amlodipine 10 mg plus olmesartan 20 mg in free combination

By Vivencio Barrios   Norbert Braun  

Current Medical Research and Opinion, Vol. 25, Iss. 9, 2009-09 ,pp. : 2267-2269

Informa Healthcare

Access to resources Recommend Favorite